1st Quarter - Report

FOLEY HOAG LLP for ELI LILLY AND COMPANY

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reauthorization of the Prescription Drug User Fee Act; Reauthorization of the Medical Device User Fee Act; H.R. 1483, Drug Safety Enhancement Act of 2011.

LobbyistCovered position, as disclosed
J KEVIN BRENNAN —
PAUL KIM —
NICK LITTLEFIELD —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1483 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.